967
Views
1
CrossRef citations to date
0
Altmetric
Pharmacoeconomic Trends

“Clinically nuanced” Medicaid cost-sharing

ORCID Icon &
Pages 189-191 | Received 22 Aug 2017, Accepted 13 Sep 2017, Published online: 21 Oct 2017
 

Transparency

Declaration of funding

There is no funding to report for this editorial.

Declaration of financial/other interests

EQC has no funding or financial relationships to declare. AMF has received funding from, or provided consulting services to, AbbVie, AHRQ, Amgen, Bayer, CalPERS, FMS Inc., Freedman Health, Gary and Mary West Health Policy Center, Janssen, Laura & John Arnold Foundation, Lilly, Mallinckrodt, MedZed, Merck, National Pharmaceutical Council, PCORI, PhRMA, Risalto, RWJ Foundation, Sempre Health, State of Michigan/CMS, State of Minnesota, State of New York, Takeda, TriZetto, Wellth, and Zansors. He is also a partner in V-BID Health, LLC. JME peer reviewers on this manuscript have no relevant financial or other relationships to disclose.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.